• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将术前放化疗治疗反应纳入局部进展期直肠癌的阳性环周切缘定义:多中心验证研究。

Redefining the Positive Circumferential Resection Margin by Incorporating Preoperative Chemoradiotherapy Treatment Response in Locally Advanced Rectal Cancer: A Multicenter Validation Study.

机构信息

Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea.

Department of Surgery, Seoul National University College of Medicine, Seoul, Korea.

出版信息

Cancer Res Treat. 2018 Apr;50(2):506-517. doi: 10.4143/crt.2016.607. Epub 2017 May 24.

DOI:10.4143/crt.2016.607
PMID:28546522
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5912136/
Abstract

PURPOSE

This study was conducted to validate the prognostic influence of treatment response among patients with positive circumferential resection margin for locally advanced rectal cancer.

MATERIALS AND METHODS

Clinical data of 197 patientswith positive circumferentialresection margin defined as ≤ 2 mm after preoperative chemoradiotherapy followed by total mesorectal excision between 2004 and 2009were collected forthis multicenter validation study. All patients underwent median 50.4Gy radiationwith concurrentfluoropyrimidine based chemotherapy. Treatmentresponse was dichotomized to good response, including treatmentresponse of grade 2 or 3, and poor response, including grade 0 or 1.

RESULTS

After 52 months median follow-up, 5-year overall survival (OS) for good responders and poor responders was 79.1% and 48.4%, respectively (p < 0.001). In multivariate analysis, circumferential resection margin involvement and treatment response were a prognosticator for OS and locoregional recurrence-free survival. In subgroup analysis, good responders with close margin showed significantly better survival outcomes for survival. Good responders with involved margin and poor responders with close margin shared similar results, whereas poorresponderswith involved margin hadworst survival (5-year OS, 81.2%, 57.0%, 50.0%, and 32.4%, respectively; p < 0.001).

CONCLUSION

Among patients with positive circumferential resection margin after preoperative chemoradiotherapy, survival of the good responders was significantly better than poor responders. Subgroup analysis revealed that definition of positive circumferential resection margin may be individualized as involvement for good responders, whereas ≤ 2 mm for poor responders.

摘要

目的

本研究旨在验证局部晚期直肠癌环周切缘阳性患者的治疗反应对预后的影响。

材料和方法

本多中心验证性研究收集了 2004 年至 2009 年间接受术前放化疗后全直肠系膜切除术且环周切缘阳性(定义为≤2mm)的 197 例患者的临床资料。所有患者均接受中位剂量为 50.4Gy 的放疗,并同步氟嘧啶类化疗。将治疗反应分为良好反应(包括 2 级或 3 级的治疗反应)和不良反应(包括 0 级或 1 级的治疗反应)。

结果

中位随访 52 个月后,良好反应组和不良反应组的 5 年总生存率(OS)分别为 79.1%和 48.4%(p<0.001)。多因素分析显示,环周切缘累及和治疗反应是 OS 和局部无复发生存的预后因素。亚组分析显示,切缘阳性且治疗反应良好的患者,局部复发风险较低,生存获益明显。切缘阳性且治疗反应不良的患者和切缘阳性且治疗反应良好的患者的生存结果相似,而切缘阳性且治疗反应不良的患者的生存结果最差(5 年 OS 分别为 81.2%、57.0%、50.0%和 32.4%;p<0.001)。

结论

在术前放化疗后环周切缘阳性的患者中,治疗反应良好的患者的生存明显优于治疗反应不良的患者。亚组分析显示,环周切缘阳性的定义可能需要个体化,对于治疗反应良好的患者,定义为累及;对于治疗反应不良的患者,定义为≤2mm。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51a6/5912136/4b2fa425675e/crt-2016-607f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51a6/5912136/563cb9fdc52c/crt-2016-607f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51a6/5912136/ea277af27285/crt-2016-607f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51a6/5912136/4b2fa425675e/crt-2016-607f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51a6/5912136/563cb9fdc52c/crt-2016-607f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51a6/5912136/ea277af27285/crt-2016-607f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51a6/5912136/4b2fa425675e/crt-2016-607f3.jpg

相似文献

1
Redefining the Positive Circumferential Resection Margin by Incorporating Preoperative Chemoradiotherapy Treatment Response in Locally Advanced Rectal Cancer: A Multicenter Validation Study.将术前放化疗治疗反应纳入局部进展期直肠癌的阳性环周切缘定义:多中心验证研究。
Cancer Res Treat. 2018 Apr;50(2):506-517. doi: 10.4143/crt.2016.607. Epub 2017 May 24.
2
Circumferential resection margin positivity after preoperative chemoradiotherapy based on magnetic resonance imaging for locally advanced rectal cancer: implication of boost radiotherapy to the involved mesorectal fascia.基于磁共振成像的术前放化疗后局部进展期直肠癌环周切缘阳性:对受累直肠系膜筋膜进行追加放疗的意义
Jpn J Clin Oncol. 2016 Apr;46(4):316-22. doi: 10.1093/jjco/hyv208. Epub 2016 Jan 21.
3
A circumferential resection margin of 1 mm is a negative prognostic factor in rectal cancer patients with and without neoadjuvant chemoradiotherapy.对于接受和未接受新辅助放化疗的直肠癌患者,1毫米的环周切缘是一个不良预后因素。
Dis Colon Rectum. 2014 Aug;57(8):933-40. doi: 10.1097/DCR.0000000000000171.
4
The influence of the treatment response on the impact of resection margin status after preoperative chemoradiotherapy in locally advanced rectal cancer.术前放化疗后,治疗反应对局部晚期直肠癌切除边缘状态影响的作用
BMC Cancer. 2013 Dec 5;13:576. doi: 10.1186/1471-2407-13-576.
5
Clinical implication of negative conversion of predicted circumferential resection margin status after preoperative chemoradiotherapy for locally advanced rectal cancer.术前放化疗后预测环周切缘状态转为阴性对局部进展期直肠癌的临床意义。
Eur J Radiol. 2014 Feb;83(2):245-9. doi: 10.1016/j.ejrad.2013.10.029. Epub 2013 Nov 7.
6
Tailored Treatment Strategy for Locally Advanced Rectal Carcinoma Based on the Tumor Response to Induction Chemotherapy: Preliminary Results of the French Phase II Multicenter GRECCAR4 Trial.基于肿瘤对诱导化疗反应的局部晚期直肠癌个体化治疗策略:法国II期多中心GRECCAR4试验的初步结果
Dis Colon Rectum. 2017 Jul;60(7):653-663. doi: 10.1097/DCR.0000000000000849.
7
Mandard tumour regression grade, perineural invasion, circumferential resection margin and post-chemoradiation nodal status strongly predict outcome in locally advanced rectal cancer treated with preoperative chemoradiotherapy.曼德尔肿瘤消退分级、神经周围侵犯、环周切缘及放化疗后淋巴结状态强烈预测术前放化疗治疗的局部晚期直肠癌的预后。
Clin Oncol (R Coll Radiol). 2014 Apr;26(4):197-202. doi: 10.1016/j.clon.2014.01.001. Epub 2014 Jan 30.
8
Prognostic significance of circumferential margin involvement in rectal adenocarcinoma treated with preoperative chemoradiotherapy and low anterior resection.术前放化疗联合低位前切除术治疗的直肠腺癌环周切缘受累的预后意义
J Surg Oncol. 2005 Apr 1;90(1):20-5. doi: 10.1002/jso.20232.
9
Prognostic value of the circumferential resection margin and its definitions in esophageal cancer patients after neoadjuvant chemoradiotherapy.新辅助放化疗后食管癌患者环周切缘的预后价值及其定义
Dis Esophagus. 2018 Feb 1;31(2). doi: 10.1093/dote/dox117.
10
Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.奥沙利铂、氟尿嘧啶和亚叶酸钙与氟尿嘧啶和亚叶酸钙作为术前放化疗后局部进展期直肠癌的辅助化疗(ADORE):一项开放标签、多中心、2 期、随机对照临床试验。
Lancet Oncol. 2014 Oct;15(11):1245-53. doi: 10.1016/S1470-2045(14)70377-8. Epub 2014 Sep 4.

引用本文的文献

1
Colorectal Cancer Surgery Quality in Manitoba: A Population-Based Descriptive Analysis.马尼托巴省结直肠癌手术质量:基于人群的描述性分析。
Curr Oncol. 2021 Jun 16;28(3):2239-2247. doi: 10.3390/curroncol28030206.
2
Microsatellite Instability Correlated Inflammatory Markers and their Prognostic Value in the Rectal Cancer Following Neoadjuvant Chemoradiotherapy: A Hypothesis-generating Study.微卫星不稳定性相关炎症标志物及其在新辅助放化疗后直肠癌中的预后价值:一项假说生成研究。
In Vivo. 2020 Jul-Aug;34(4):2119-2126. doi: 10.21873/invivo.12017.

本文引用的文献

1
Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04.卡培他滨与奥沙利铂用于直肠癌术前多模式治疗:来自国家外科辅助乳腺和肠道项目R-04试验的手术终点
J Clin Oncol. 2014 Jun 20;32(18):1927-34. doi: 10.1200/JCO.2013.53.7753. Epub 2014 May 5.
2
Intraoperative radiation therapy reduces local recurrence rates in patients with microscopically involved circumferential resection margins after resection of locally advanced rectal cancer.术中放疗降低了局部进展期直肠癌根治术后切缘镜下阳性患者的局部复发率。
Int J Radiat Oncol Biol Phys. 2014 Apr 1;88(5):1032-40. doi: 10.1016/j.ijrobp.2014.01.014.
3
The influence of the treatment response on the impact of resection margin status after preoperative chemoradiotherapy in locally advanced rectal cancer.
术前放化疗后,治疗反应对局部晚期直肠癌切除边缘状态影响的作用
BMC Cancer. 2013 Dec 5;13:576. doi: 10.1186/1471-2407-13-576.
4
What is the significance of the circumferential margin in locally advanced rectal cancer after neoadjuvant chemoradiotherapy?新辅助放化疗后局部进展期直肠癌环周切缘的意义是什么?
Ann Surg Oncol. 2013 Apr;20(4):1179-84. doi: 10.1245/s10434-012-2722-7. Epub 2013 Jan 18.
5
Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial.局部进展期直肠癌的术前放化疗和术后氟尿嘧啶与奥沙利铂联合化疗与单纯氟尿嘧啶化疗的比较:德国 CAO/ARO/AIO-04 随机 3 期临床试验的初步结果。
Lancet Oncol. 2012 Jul;13(7):679-87. doi: 10.1016/S1470-2045(12)70187-0. Epub 2012 May 23.
6
Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial.局部进展期直肠癌术前放化疗加或不加奥沙利铂的原发肿瘤反应:STAR-01 随机 III 期临床试验的病理结果。
J Clin Oncol. 2011 Jul 10;29(20):2773-80. doi: 10.1200/JCO.2010.34.4911. Epub 2011 May 23.
7
Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2.比较两种局部晚期直肠癌新辅助放化疗方案:ACCORD 12/0405-Prodige 2 期临床试验结果。
J Clin Oncol. 2010 Apr 1;28(10):1638-44. doi: 10.1200/JCO.2009.25.8376. Epub 2010 Mar 1.
8
Circumferential resection margin as a prognostic factor in rectal cancer.环周切缘作为直肠癌的一个预后因素。
Br J Surg. 2009 Nov;96(11):1348-57. doi: 10.1002/bjs.6739.
9
Pathologic nodal classification is the most discriminating prognostic factor for disease-free survival in rectal cancer patients treated with preoperative chemoradiotherapy and curative resection.病理性淋巴结分类是术前放化疗和根治性切除治疗的直肠癌患者无病生存的最具鉴别力的预后因素。
Int J Radiat Oncol Biol Phys. 2010 Jul 15;77(4):1158-65. doi: 10.1016/j.ijrobp.2009.06.019. Epub 2009 Sep 30.
10
Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial.直肠癌患者术前放疗与选择性术后放化疗的比较(MRC CR07和NCIC-CTG C016):一项多中心随机试验
Lancet. 2009 Mar 7;373(9666):811-20. doi: 10.1016/S0140-6736(09)60484-0.